Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brains.

"Declarations Ethical approval and consent to participateAll animal experiments were approved by the Animal Welfare Committee of Université Laval in accordance with the Canadian Council on Animal Care policy (authorization # 2020 − 641). Consent for publicationAll authors have given their consent for publication. Competing interestsThe authors declare that they have no competing interests. Authors’ informationNot applicable. Competing interests The authors declare that they have no competing interests."

"Funding This work was supported by the Canadian Institutes of Health Research (CIHR). AO was supported by Junior 1 and Junior 2 salary Awards from the Fonds de Recherche du Québec – Santé (FRQS) and la Société Parkinson du Québec. MB was supported by scholarships from the Fondation du CHU de Québec, Faculty of Medicine of Université Laval (Bourse de recrutement du doctorat Pierre J. Durant), and FRQS."